Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Provencher, S.
Right arrow Articles by Simonneau, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Provencher, S.
Right arrow Articles by Simonneau, G.
(Chest. 2005;128:622S-628S.)
© 2005 American College of Chest Physicians

Clinical Challenges in Pulmonary Hypertension*

Roger S. Mitchell Lecture

Steeve Provencher, MD; Xavier Jais, MD; Azzedine Yaici, MD; Olivier Sitbon, MD; Marc Humbert, MD, PhD and Gérald Simonneau, MD

* From the Centre des Maladies Vasculaires Pulmonaires (UPRES EA 2705), Service de Pneumologie et Réanimation Respiratoire, AP-HP-Université Paris Sud XI, Hôpital Antoine Béclère, Clamart, France.

Correspondence to: Steeve Provencher, MD, Hôpital Antoine Béclère, 157 rue de la Porte de Trivaux, 92140 Clamart, France; e-mail: steeveprovencher{at}hotmail.com

Despite major advances in our understanding of the pathophysiologic processes leading to pulmonary arterial hypertension and recent developments in therapeutic approaches, the long-term prognosis for patients with pulmonary arterial hypertension remains unsatisfactory. Early detection and adequate clinical classification of the disease, better assessment of patients’ prognosis, and improved therapeutic strategies are important challenges for clinicians in coming years.

Key Words: chronic thromboembolic pulmonary hypertension • combination therapy • early detection • venoocclusive disease • walk test






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.